Breaking News Instant updates and real-time market news.

BA

Boeing

$367.15

-7.9 (-2.11%)

13:31
06/27/19
06/27
13:31
06/27/19
13:31

Jefferies pushes back view of Boeing restarting 737 MAX deliveries to Q4

After Boeing disclosed in a filing that the FAA has requested the company address software changes to the 737 MAX that the company has been developing for the past 8 months and will not offer the 737 MAX for certification by the FAA until all requirements are satisfied, Jefferies analyst Sheila Kahyaoglu said she now does not expect that 737 MAX deliveries will restart until Q4, pushed back from her previous expectation for a restart of deliveries in Q3. She still forecasts 737 MAX deliveries of 179 in Q4, but removed the 126 MAXs she previously forecasted in Q3, which resulted in her 2019 EPS estimate being cut to $12.75 from $14.70. Kahyaoglu, who thinks Boeing should be able to recover the lost deliveries once the final fix is in place, keeps a Buy rating on the stock.

  • 09

    Jul

  • 24

    Jul

BA Boeing
$367.15

-7.9 (-2.11%)

06/11/19
JEFF
06/11/19
NO CHANGE
Target $448
JEFF
Buy
Boeing's May deliveries 'weak' due to 737 MAX grounding, says Jefferies
Boeing delivered 30 commercial aircraft in May vs. 68 a year ago, Jefferies analyst Sheila Kahyaoglu tells investors in a research note, saying that the deliveries were weak given the 737 MAX grounding. The analyst continues to forecast Q2 deliveries of 77 and FY19 deliveries of 665, assuming no 737 MAX deliveries until Q3, and sees the Paris Air Show as a potential pick up in order activity. Kahyaoglu has a Buy rating and $448 price target on Boeing shares.
06/18/19
BOFA
06/18/19
NO CHANGE
Target $420
BOFA
Neutral
Boeing 737 MAX rebranding wouldn't fix issues, says BofA/Merrill
BofA/Merrill analyst Ronald Epstein commented on Day 1 of the Paris Air Show, telling investors that "there were more questions than answers" regarding Boeing's 737 MAX. In a research note to investors, Epstein says his team's conversations with suppliers and other industry participants did not provide additional clarity on the certification of the 737 MAX, and says Boeing appears to be using the show as opportunity to explain what has gone wrong with 737 Max program, adding that he is "surprised" that the 737 MAX is in the position that it is. Epstein also notes that a rebranding effort for the 737 MAX would likely not fix the confidence issues facing the MAX, as "A rose by any other name would smell as sweet."
06/27/19
UBSW
06/27/19
NO CHANGE
Target $500
UBSW
Buy
Sentiment improving on willingness to fly on Boeing 737 MAX, says UBS
UBS analyst Myles Walton says his firm's UBS Evidence Lab surveyed the public on how they view Boeing's 737 MAX. Walton tells investors investors in a research note that he believes a single point in time survey does not capture ongoing consumer sentiment which can change relatively quickly, and that while the overall story of this survey is similar to the previous survey, "we did note some improvement in sentiment around consumers' willingness to fly on a 737 MAX." Walton has a Buy rating and $500 price target on Boeing shares.
06/27/19
BOFA
06/27/19
NO CHANGE
Target $420
BOFA
Neutral
BofA continues to see 6-9 month MAX grounding after Boeing's latest 'hiccup'
After the FAA announced that it "recently found a potential risk that Boeing must mitigate" before returning the 737 MAX to service, BofA Merrill Lynch analyst Ronald Epstein said it is his understanding that this is a separate issue from the MAX's Maneuvering Characteristics Augmentation System, but one that surfaced during FAA MCAS-related simulator testing. It is not surprising to Epstein that the FAA identified another potential risk during the review of Boeing's MCAS fix, the analyst said, adding that he would expect to see some back and forth before a final fix is determined. Epstein sees no change to his original estimated timeframe of a 6-9 month delay and keeps a Neutral rating on Boeing shares, adding that he would need to revisit his financial forecasts if the MAX grounding extends beyond this timeframe.

TODAY'S FREE FLY STORIES

AMZN

Amazon.com

$1,978.35

-14.06 (-0.71%)

05:59
07/19/19
07/19
05:59
07/19/19
05:59
Periodicals
Amazon hiring for 'stealth advertising innovation' team, Business Insider says »

Amazon is hiring for two…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

TM

Toyota

$129.88

0.625 (0.48%)

05:57
07/19/19
07/19
05:57
07/19/19
05:57
Hot Stocks
Toyota, BYD enter agreement to jointly develop battery electric vehicles »

BYD Company and Toyota…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WE

We Company

$0.00

(0.00%)

05:55
07/19/19
07/19
05:55
07/19/19
05:55
Periodicals
We Company to host analyst day for Wall Street banks on July 31, Reuters reports »

WeWork parent The We…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JCP

J.C. Penney

$1.08

-0.06 (-5.29%)

05:53
07/19/19
07/19
05:53
07/19/19
05:53
Periodicals
J.C. Penney hires advisers to explore debt restructuring options, Reuters says »

J.C. Penney has hired…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BAYRY

Bayer

$0.00

(0.00%)

05:50
07/19/19
07/19
05:50
07/19/19
05:50
Periodicals
Bayer welcomes decision for reduced damages in Roundup case, Reuters reports »

Bayer says it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

MDLA

Medallia

$0.00

(0.00%)

05:49
07/19/19
07/19
05:49
07/19/19
05:49
Syndicate
Medallia 15.5M share IPO price $21.00 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

IFS

Intercorp Financial Services

$0.00

(0.00%)

05:46
07/19/19
07/19
05:46
07/19/19
05:46
Syndicate
Intercorp Financial Services 9M share IPO priced at $46.00 »

The deal range was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

CRWD

Crowdstrike

$72.75

1.77 (2.49%)

05:45
07/19/19
07/19
05:45
07/19/19
05:45
Recommendations
Crowdstrike analyst commentary  »

Crowdstrike price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AFYA

Afya

$0.00

(0.00%)

05:44
07/19/19
07/19
05:44
07/19/19
05:44
Syndicate
Afya 13.744M share IPO priced at $19.00 »

The deal priced above the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

OXY

Occidental Petroleum

$51.01

-0.18 (-0.35%)

, APC

Anadarko

$72.97

-0.16 (-0.22%)

05:42
07/19/19
07/19
05:42
07/19/19
05:42
Hot Stocks
Carl Icahn formally seeks to replace four Occidental Petroleum directors »

Carl Icahn filed a…

OXY

Occidental Petroleum

$51.01

-0.18 (-0.35%)

APC

Anadarko

$72.97

-0.16 (-0.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

  • 08

    Aug

  • 27

    Aug

MSFT

Microsoft

$136.29

0.06 (0.04%)

, IBM

IBM

$149.63

6.56 (4.59%)

05:42
07/19/19
07/19
05:42
07/19/19
05:42
Recommendations
Microsoft, IBM, Oracle, SAP analyst commentary  »

Microsoft price target…

MSFT

Microsoft

$136.29

0.06 (0.04%)

IBM

IBM

$149.63

6.56 (4.59%)

ORCL

Oracle

$58.13

0.13 (0.22%)

SAP

SAP

$127.28

-6.94 (-5.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

  • 01

    Aug

  • 03

    Aug

  • 06

    Aug

  • 06

    Aug

  • 08

    Aug

AMRN

Amarin

$18.90

-2.16 (-10.26%)

05:42
07/19/19
07/19
05:42
07/19/19
05:42
Syndicate
Amarin 22.222M share Secondary priced at $18.00 »

JPMorgan, Goldman Sachs,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

  • 19

    Jul

SCHW

Charles Schwab

$41.48

0.28 (0.68%)

05:40
07/19/19
07/19
05:40
07/19/19
05:40
Conference/Events
Charles Schwab to host business news update conference call »

Conference call to be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

  • 27

    Oct

SUN

Sunoco

$32.92

-0.26 (-0.78%)

05:38
07/19/19
07/19
05:38
07/19/19
05:38
Initiation
Sunoco initiated  »

Sunoco initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BUD

AB InBev

$89.38

0.96 (1.09%)

05:37
07/19/19
07/19
05:37
07/19/19
05:37
Hot Stocks
AB InBev continues to evaluate potential IPO of Budweiser APAC »

AB InBev said in a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

BUD

AB InBev

$89.38

0.96 (1.09%)

05:36
07/19/19
07/19
05:36
07/19/19
05:36
Hot Stocks
AB InBev to sell Carlton & United Breweries for $11.3B to Asahi Group »

Anheuser-Busch InBev has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

WE

We Company

$0.00

(0.00%)

05:33
07/19/19
07/19
05:33
07/19/19
05:33
Periodicals
WeWork co-founder has cashed out over $700M ahead of IPO, WSJ reports »

Adam Neumann, the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARDS

Aridis Pharmaceuticals

$9.80

(0.00%)

05:31
07/19/19
07/19
05:31
07/19/19
05:31
Hot Stocks
Aridis Pharmaceuticals receives Orphan Drug Designation from EMA for AR-501 »

Aridis Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Aug

PEP

PepsiCo

$132.87

0.1 (0.08%)

05:26
07/19/19
07/19
05:26
07/19/19
05:26
Hot Stocks
PepsiCo to acquire Pioneer Foods for $1.7B »

PepsiCo announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NDAQ

Nasdaq

$103.13

0.53 (0.52%)

05:23
07/19/19
07/19
05:23
07/19/19
05:23
Hot Stocks
Nasdaq, Iraq Stock Exchange sign new market technology agreement »

Nasdaq and the Iraq Stock…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

TTWO

Take-Two

$117.68

0.04 (0.03%)

, ATVI

Activision Blizzard

$45.71

-0.98 (-2.10%)

05:13
07/19/19
07/19
05:13
07/19/19
05:13
Recommendations
Take-Two, Activision Blizzard, Electronic Arts analyst commentary at Piper Jaffray »

June quarter NPD data…

TTWO

Take-Two

$117.68

0.04 (0.03%)

ATVI

Activision Blizzard

$45.71

-0.98 (-2.10%)

EA

Electronic Arts

$89.21

-0.51 (-0.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

  • 30

    Jul

  • 05

    Aug

  • 08

    Aug

  • 08

    Aug

  • 05

    Sep

  • 13

    Nov

AMGN

Amgen

$179.53

2.47 (1.40%)

, AGN

Allergan

$161.93

-0.64 (-0.39%)

05:10
07/19/19
07/19
05:10
07/19/19
05:10
Hot Stocks
Amgen, Allergan say Mvasi, Kanjinti now available in U.S. »

Amgen (AMGN) and Allergan…

AMGN

Amgen

$179.53

2.47 (1.40%)

AGN

Allergan

$161.93

-0.64 (-0.39%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jul

  • 09

    Sep

  • 16

    Sep

  • 02

    Oct

MSFT

Microsoft

$136.29

0.06 (0.04%)

05:09
07/19/19
07/19
05:09
07/19/19
05:09
Recommendations
Microsoft analyst commentary  »

Jefferies boosts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Aug

  • 06

    Aug

  • 08

    Aug

CRWD

Crowdstrike

$72.75

1.77 (2.49%)

05:06
07/19/19
07/19
05:06
07/19/19
05:06
Recommendations
Crowdstrike analyst commentary  »

Crowdstrike price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SMSI

Smith Micro

$3.12

0.04 (1.30%)

05:03
07/19/19
07/19
05:03
07/19/19
05:03
Initiation
Smith Micro initiated  »

Smith Micro initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.